Elevance Health Officers Intend To Reaffirm Cos Net Income Guidance For FY23 To Be Greater Than $29.09/Share; Excluding These Items, Sees Adjusted Net Income To Be Greater Than $32.85/Share For FY23; FY23 Share View $32.93
Portfolio Pulse from Benzinga Newsdesk
Elevance Health Officers have announced their intention to reaffirm the company's net income guidance for FY23 to be greater than $29.09 per share. Excluding certain items, the adjusted net income is expected to be greater than $32.85 per share for FY23. The FY23 share view is $32.93.
September 20, 2023 | 3:52 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Elevance Health's reaffirmation of its FY23 net income guidance could potentially boost investor confidence and positively impact the company's stock price.
Elevance Health's reaffirmation of its FY23 net income guidance indicates the company's confidence in its financial performance. This could potentially boost investor confidence and lead to an increase in the company's stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100